# GRAIL Inc. (GRAL)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/GRAL/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 85.47M | $ -203.43M | $ -168.65M | $ 91.31M | $ 2.54B |
| 2025 | $ 150.69M | $ -418.12M | $ -306.16M | $ 98.01M | $ 2.58B |
| 2024 | $ 132.01M | $ -2.13B | $ -612.11M | $ 68.14M | $ 2.50B |
| 2023 | $ 100.67M | $ -1.39B | $ -658.14M | $ 84.41M | $ 3.65B |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.04 |
| Liabilities / Eq | 0.12 |
| Current Ratio | 10.95 |

## Other views

- [Metrics](https://sponda.capital/en/GRAL.md)
- [Charts](https://sponda.capital/en/GRAL/charts.md)
- [Compare](https://sponda.capital/en/GRAL/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.